WO2008006082A3 - Energy enhancing formulation - Google Patents

Energy enhancing formulation Download PDF

Info

Publication number
WO2008006082A3
WO2008006082A3 PCT/US2007/072982 US2007072982W WO2008006082A3 WO 2008006082 A3 WO2008006082 A3 WO 2008006082A3 US 2007072982 W US2007072982 W US 2007072982W WO 2008006082 A3 WO2008006082 A3 WO 2008006082A3
Authority
WO
WIPO (PCT)
Prior art keywords
formulation
energy enhancing
enhancing formulation
mulungu
theanine
Prior art date
Application number
PCT/US2007/072982
Other languages
French (fr)
Other versions
WO2008006082A2 (en
Inventor
Jon Barron
Original Assignee
Jon Barron
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jon Barron filed Critical Jon Barron
Publication of WO2008006082A2 publication Critical patent/WO2008006082A2/en
Publication of WO2008006082A3 publication Critical patent/WO2008006082A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

An herbal formulation comprising mulungu, Bacopa monniera, green tea extract, L-theanine and, optionally, stevia is provided. The formulation, in preferred embodiments, energizes both the mind and body, stimulates the pleasure centers in the brain and body and acts as an appetite suppressant.
PCT/US2007/072982 2006-07-06 2007-07-06 Energy enhancing formulation WO2008006082A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81884606P 2006-07-06 2006-07-06
US60/818,846 2006-07-06

Publications (2)

Publication Number Publication Date
WO2008006082A2 WO2008006082A2 (en) 2008-01-10
WO2008006082A3 true WO2008006082A3 (en) 2008-02-28

Family

ID=38895503

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/072982 WO2008006082A2 (en) 2006-07-06 2007-07-06 Energy enhancing formulation

Country Status (1)

Country Link
WO (1) WO2008006082A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2255726A1 (en) * 2009-05-26 2010-12-01 Sanofi-Aventis Spectral profile of SWS enhancing drugs
US20130165398A1 (en) 2010-03-29 2013-06-27 Paul Hochegger Concentration-enhancing drink
WO2012054743A2 (en) * 2010-10-20 2012-04-26 Yongquan Xue Taste modifying compositions
EP2574339A1 (en) 2011-09-27 2013-04-03 Johannes Huber Pharmaceutical preparation for treating NADH-related illnesses
CA2941099A1 (en) * 2014-02-28 2015-09-03 Matthew L. Tripp Phosphodiesterase inhibiting phytochemical compositions
WO2017200391A1 (en) * 2016-05-17 2017-11-23 Alphagen Nz Limited Compositions comprising l-theanine, proanthocyanidin/s and a catechin and uses thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736575A (en) * 1995-10-03 1998-04-07 Ito En Ltd. Excitement accelerating agent

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736575A (en) * 1995-10-03 1998-04-07 Ito En Ltd. Excitement accelerating agent

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
"the barron report", vol. 13, no. 2, 2004, pages 1 - 4, Retrieved from the Internet <URL:http://www.jonbarron.org/barron_reports/2-1-2004.php> *

Also Published As

Publication number Publication date
WO2008006082A2 (en) 2008-01-10

Similar Documents

Publication Publication Date Title
IL178402A0 (en) 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
IL180284A0 (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
EP2193721A4 (en) Tea extract, tea drink and method of producing the same
HK1105161A1 (en) Concentrated coffee extract and process for producing the same
EP1750754A4 (en) Human glp-1 mimetibodies, compositions, methods and uses
CA121967S (en) Iron golf club head
EP1784163A4 (en) Nano-emulsion, the use thereof, and preparation method thereof
ZA200703876B (en) 2-amido -4-phenylthiazole derivatives, the preparation and therapeutic use thereof
SI1773796T1 (en) Oxopiperidine derivatives, preparation and therapeutic use thereof
PL1945040T3 (en) Method for preparing a coffee extract, and the extract to be obtained therewith
IL216238A0 (en) 7-aza-spiro[3.5]nonane-7-carboxylate derivatives, preparation thereof, and therapeutic use thereof
TWI350287B (en) Acylaminothiazole derivatives, their preparation and their therapeutic application
WO2008006082A3 (en) Energy enhancing formulation
PL2205593T3 (en) Quinazolinedione derivatives, preparation thereof and therapeutic uses thereof
EP1978983A4 (en) Extract of dioscorea sp. and the medical uses thereof
IL180797A0 (en) Amino-tropane derivatives, preparation thereof and therapeutic use thereof
IL190519A0 (en) 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof
WO2009151300A3 (en) Extract of coptidis rhizoma and use thereof in treating respiratory disease
EP2083011A4 (en) Pyrroline derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof
ZA200903865B (en) Pyrrole derivatives, preparation and use of the same in therapy
EP1813288A4 (en) Medicinal composition, medicinal preparation, and combination preparation
HK1139671A1 (en) Azabicycloalkane derivatives, preparation thereof and use thereof in therapy
IL195096A0 (en) Aqueous tobacco leaf extract, uses thereof in the treatment of dependence
HK1103279A1 (en) Composition, extract thereof and pharmaceutical use thereof
TWI340642B (en) Acylaminothiazole derivatives, preparation and therapeutic application thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07812691

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07812691

Country of ref document: EP

Kind code of ref document: A2